Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Details

Ressource 1Download: 28992817_BIB_E2ECB8F026E5.pdf (1698.62 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_E2ECB8F026E5
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).
Journal
Journal of cardiovascular magnetic resonance
Author(s)
Messroghli D.R., Moon J.C., Ferreira V.M., Grosse-Wortmann L., He T., Kellman P., Mascherbauer J., Nezafat R., Salerno M., Schelbert E.B., Taylor A.J., Thompson R., Ugander M., van Heeswijk R.B., Friedrich M.G.
ISSN
1532-429X (Electronic)
ISSN-L
1097-6647
Publication state
Published
Issued date
09/10/2017
Peer-reviewed
Oui
Volume
19
Number
1
Pages
75
Language
english
Notes
Publication types: Consensus Development Conference ; Journal Article
Publication Status: epublish
Abstract
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR). Parametric mapping with CMR now permits the routine spatial visualization and quantification of changes in myocardial composition based on changes in T1, T2, and T2*(star) relaxation times and extracellular volume (ECV). These changes include specific disease pathways related to mainly intracellular disturbances of the cardiomyocyte (e.g., iron overload, or glycosphingolipid accumulation in Anderson-Fabry disease); extracellular disturbances in the myocardial interstitium (e.g., myocardial fibrosis or cardiac amyloidosis from accumulation of collagen or amyloid proteins, respectively); or both (myocardial edema with increased intracellular and/or extracellular water). Parametric mapping promises improvements in patient care through advances in quantitative diagnostics, inter- and intra-patient comparability, and relatedly improvements in treatment. There is a multitude of technical approaches and potential applications. This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
Keywords
Consensus, Europe, Heart/diagnostic imaging, Heart Diseases/diagnostic imaging, Humans, Image Processing, Computer-Assisted/methods, Magnetic Resonance Imaging/methods, Societies, Medical
Pubmed
Web of science
Open Access
Yes
Create date
19/10/2017 8:15
Last modification date
20/08/2019 16:06
Usage data